SUNPHARMA — Sun Pharmaceutical Industries Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	50,096	27,994	44,813	94,084	110,879
Depreciation
Non-Cash Items	-602	-2,701	-1,688	1,931	-10,022
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,474	15,612	25,697	-66,050	-5,060
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	65,548	61,704	90,260	55,260	121,363
Capital Expenditures	-15,420	-11,701	-14,950	-20,856	-22,018
Purchase of Fixed Assets
Other Investing Cash Flow Items	-10,468	17,064	-42,297	-58,581	15,116
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-25,888	5,362	-57,247	-79,437	-6,902
Financing Cash Flow Items	-12,130	686	-2,692	-1,001	-2,990
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-57,151	-59,805	-51,935	23,761	-67,102
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-13,857	5,964	-17,648	1,155	46,619